Maggie Wong is a partner in Goodwin’s Life Sciences group, representing private and public companies in the biotechnology, medical device and digital health industries and serving as a legal and business adviser across their entire corporate lifecycle. Maggie provides strategic advice and corporate counseling to clients as they in-license and acquire IP and other assets, raise capital to fund their operations and seek to partner their technology or engage in exit transactions. She regularly counsels clients on pre-incorporation planning, seed and venture financings, IPOs and capital markets transactions, SEC compliance, and M+A and has substantial experience advising on licensing, collaboration, partnering, distribution and other commercial agreements. Maggie is a member of Goodwin’s PropSci practice, which supports the real estate needs of life sciences companies. She is also the San Francisco office Co-chair for the firm’s women’s initiative – Women@Goodwin.
As a result of these efforts, Maggie has received national recognition. She has repeatedly been named an LMG Life Sciences Star for Corporate, Licensing & Collaboration, Mergers & Acquisitions and Venture Capital matters. The Legal 500 US has ranked Maggie as a key Life Sciences lawyer, with clients describing her as, “a tireless resource who is always available, provides rapid and actionable feedback, and loops in colleagues as needed for specific expertise. She is willing and able to meet our colleagues at their level of experience and support the execution of simple and complex transactions.”